- Home
- RCUS vs CDNA Comparison
RCUS vs CDNA Comparison
Compare RCUS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- CDNA
- Stock Information
- Founded
- RCUS 2015
- CDNA 1998
- Country
- RCUS United States
- CDNA United States
- Employees
- RCUS N/A
- CDNA N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- CDNA Medical Specialities
- Sector
- RCUS Health Care
- CDNA Health Care
- Exchange
- RCUS Nasdaq
- CDNA Nasdaq
- Market Cap
- RCUS 1.2B
- CDNA 1.1B
- IPO Year
- RCUS 2018
- CDNA 2014
- Fundamental
- Price
- RCUS $8.17
- CDNA $17.96
- Analyst Decision
- RCUS Strong Buy
- CDNA Buy
- Analyst Count
- RCUS 10
- CDNA 8
- Target Price
- RCUS $29.50
- CDNA $29.43
- AVG Volume (30 Days)
- RCUS 907.7K
- CDNA 723.1K
- Earning Date
- RCUS 05-07-2025
- CDNA 05-08-2025
- Dividend Yield
- RCUS N/A
- CDNA N/A
- EPS Growth
- RCUS N/A
- CDNA N/A
- EPS
- RCUS N/A
- CDNA 0.93
- Revenue
- RCUS $258,000,000.00
- CDNA $333,785,000.00
- Revenue This Year
- RCUS N/A
- CDNA $13.32
- Revenue Next Year
- RCUS $28.07
- CDNA $14.99
- P/E Ratio
- RCUS N/A
- CDNA $19.31
- Revenue Growth
- RCUS 120.51
- CDNA 19.07
- 52 Week Low
- RCUS $8.02
- CDNA $7.42
- 52 Week High
- RCUS $18.98
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- RCUS 30.17
- CDNA 38.18
- Support Level
- RCUS $8.02
- CDNA $18.16
- Resistance Level
- RCUS $9.19
- CDNA $20.00
- Average True Range (ATR)
- RCUS 0.46
- CDNA 0.84
- MACD
- RCUS 0.01
- CDNA 0.05
- Stochastic Oscillator
- RCUS 7.46
- CDNA 17.74
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.